欧洲 · 交易所与实时行情 · Finanzen.net
EQS-News: Immunic to Host Virtual Progressive Multiple Sclerosis R&D Day on November 5, 2026
NEW YORK, October 29, 2026 – Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today…
在 Finanzen.net 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.finanzen.net)
